ATC Group: A01AB23 Minocycline

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A01AB23 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Stomatological preparations
3
Stomatological preparations
4
Antiinfectives and antiseptics for local oral treatment
5
A01AB23
Minocycline

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
1 mg

Active ingredients in A01AB23

Active Ingredient
Description

Minocycline is a semi-synthetic derivative of tetracycline. Minocycline inhibits protein synthesis in susceptible bacteria. In common with other tetracyclines it is primarily bacteriostatic and has a similar spectrum of activity to other tetracyclines.

Medicines in this ATC group

Drug
Countries

Canada United States

Ireland United Kingdom

Ecuador Ireland Spain United Kingdom United States ...

Singapore

Related product monographs

Title
Type
Country
Structured Product Labeling (SPL)
US
Summary of Product Characteristics (SPC)
IE